Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir by Mallal S, Nolan D, Witt C, Masel G, Martin A M, Moore C, Sayer D, Castley A, Mamotte C, Maxwell D, James I, Christiansen F T in Lancet (2002).

[PMID: 11888582] PubMed

Abstract

Discussed In Paper

Loading...

Variant Annotations

Sign in to see variant annotations.

Dosing Information

No dosing information annotated.